6
Phase 2–4 trials
MASH / liver disease · Live ClinicalTrials.gov data
Efruxifermin clinical trial pipeline
ClinicalTrials.gov lists 6 phase 2–4 trials for efruxifermin, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Feb 2030. Refreshed daily. Add up to four competitors to compare pipelines side by side.
3
Phase 3 trials
2
Actively recruiting
Feb 2030
Next phase 3 primary completion
4,951
Participants across trials
Akero Therapeutics, Inc
Lead sponsor by trial count
efruxifermin (6)3 active2019–2034
efruxifermin
'19
'21
'23
'25
'27
'29
'31
'33
efruxifermin
A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)P2
HarmonyP2
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)P2
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)P3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisP3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHP3
Upcoming readouts
2 ahead · efruxifermin
Select a trial to load its full ClinicalTrials.gov record.
Key efruxifermin trials
Top 6 of the 6 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06528314 | A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase 3 | Recruiting | Feb 2030 |
| NCT06215716 | A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS… | Phase 3 | Recruiting | Feb 2033 |
| NCT06161571 | A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohep… | Phase 3 | Active, not recruiting | Mar 2026 |
| NCT03976401 | A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (… | Phase 2 | Completed | Feb 2021 |
| NCT05039450 | A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatit… | Phase 2 | Completed | Dec 2023 |
| NCT04767529 | Harmony: A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Ste… | Phase 2 | Completed | May 2024 |
Track efruxifermin with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for efruxifermin?
- ClinicalTrials.gov currently lists 6 phase 2–4 efruxifermin trials: 3 phase 2, 3 phase 3, and 0 phase 4. 2 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare efruxifermin against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
